SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   FORM 10-K/A
                                 Amendment No. 1
[X]             ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                   For the fiscal year ended December 31, 1996
                                       OR
[   ]           TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

           For the transition period from _____________ to ___________

                         Commission file number 0-21104

                                 CRYOLIFE, INC.
             (Exact name of registrant as specified in its charter)

         Florida                                              59-2417093
(State or other jurisdiction of                           (I.R.S. Employer
 incorporation or organization)                          Identification No.)

                 1655 Roberts Boulevard N.W., Kennesaw, GA 30144
               (Address of principal executive offices) (zip code)

Registrant's telephone number, including area code         (770) 419-3355

Securities registered pursuant to Section 12(b) of the Act:

                                                     Name of each exchange on
Title of each class                                      which registered

None                                                     Not applicable

Securities registered pursuant to Section 12(g) of the Act:

                          Common Stock, $.01 par value
                                (Title of Class)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or such shorter period that the registrant was required
to file such reports),  and (2) has been subject to such filing requirements for
the past 90 days.
                       [X] Yes                   [ ] No

Indicate by check mark if disclosure of delinquent  filers  pursuant to Item 405
of Regulation  S-K is not contained  herein,  and will not be contained,  to the
best of registrant's  knowledge,  in definitive proxy or information  statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ ]

The  aggregate  market  value  of  voting  stock  held by  nonaffiliates  of the
registrant was approximately  $77,208,000 at March 18, 1997 (7,720,772  shares).
The  number  of  common  shares  outstanding  at March  18,  1997 was  9,585,808
(exclusive of treasury shares).



506213.1







The Registrant is hereby filing Amendment No. 1 to Form 10-K for the fiscal year
ended  December  31,  1996  for  the  purpose  of  filing  Exhibit  10.9(g). 

                                     PART IV

Item 14.       Exhibits, Financial Statement Schedules, and Reports on Form 8-K.

         The following are filed as part of this report:

               (a)      1.       Financial Statements

               The following  consolidated financial statements are incorporated
         herein by reference to the 1996 Annual Report to Stockholders, portions
         of which are filed as an exhibit to this Form 10-K.

               Consolidated  Statements of Income for each of the three years in
               the period ended December 31, 1996, page 12.

               Consolidated  Statements of Shareholders'  Equity for each of the
               three years in the period ended December 31, 1996, page 14.

               Consolidated  Balance  Sheets as of  December  31, 1996 and 1995,
               pages 10 through 11.

               Consolidated Statements of Cash Flows for each of the three years
               in the period ended December 31, 1996, page 13.

               Notes to Consolidated Financial Statements, pages 15 through 21.

               Independent Auditors' Report, page 22.


                        2.       Financial Statement Schedule

               Independent Auditors' Report on Schedule

               Schedule II - Valuation and Qualifying Accounts


All other  financial  statement  schedules not listed above are omitted,  as the
required  information is not  applicable or the  information is presented in the
consolidated financial statements or related notes.






506213.1
                                       -2-





                           3.       A.      Exhibits

The following exhibits are filed herewith or incorporated herein by reference:

Exhibit
Number             Description
- -------            -----------  
2.1*           Sale  Agreement  dated  August 16,  1996  between the Company and
               Donald Nixon Ross.  (Incorporated  by reference to Exhibit 2.1 to
               the  Registrant's  Quarterly  report on form 10-Q for the quarter
               ended September 30, 1996.)

2.2*           Asset   Purchase   Agreement   among  the   Company   and  United
               Cryopreservation  Foundation, Inc., United Transplant Foundation,
               Inc. and QV, Inc.  dated  September  11, 1996.  (Incorporated  by
               reference to Exhibit 2.2 to the Registrant's  Quarterly Report on
               Form 10-Q for the quarter ended September 30, 1996.)

3.1*           Restated Certificate of Incorporation of the Company, as amended.
               (Incorporated  by  reference  to Exhibit 3.1 to the  Registrant's
               Registration Statement on Form S-1 (No. 33-56388).)

3.2*           Amendment  to Articles  of  Incorporation  of the  Company  dated
               November 29, 1995.  (Incorporated  by reference to Exhibit 3.2 to
               the  Registrant's  Annual Report on Form 10-K for the fiscal year
               ended December 31, 1995.)

3.3*           Amendment to the Company's  Articles of Incorporation to increase
               the number of  authorized  shares of common stock from 20 million
               to 50  million  shares  and to delete  the  requirement  that all
               preferred  shares  have  one  vote per  share.  (Incorporated  by
               reference to Exhibit 3.3 to the Registrant's  Quarterly Report on
               Form 10-Q for the quarter ended June 30, 1996.)

3.4*           ByLaws of the Company, as amended.  (Incorporated by reference to
               Exhibit 3.2 to the  Registrant's  Annual  Report on Form 10-K for
               the fiscal year ended December 31, 1995.)

4.1*           Form of Certificate for the Company's Common Stock. (Incorporated
               by  reference  to Exhibit  4.1 to the  Registrant's  Registration
               Statement on Form S-1 (No. 33-56388).)

10.1*          Lease, by and between New Market Partners III, Laing  Properties,
               Inc., General Partner,  as Landlord,  and the Company, as Tenant,
               dated  February 13, 1986, as amended by that  Amendment to Lease,
               by and between the  parties,  dated April 7, 1986,  as amended by
               that  Amendment to Lease,  by and between the parties,  dated May
               15, 1987,  as amended by that Second  Amendment to Lease,  by and
               between  the  parties,  dated June 22,  1988,  as amended by that
               Third Amendment to Lease, by and between the parties, dated April
               4, 1989,  as amended by that Fourth  Amendment  to Lease,  by and
               between the parties, dated April 4, 1989 as amended by that Fifth
               Amendment to Lease, by and between the parties, dated October 15,
               1990.   (Incorporated   by  reference  to  Exhibit  10.1  to  the
               Registrant's Registration Statement on Form S-1 (No. 33-56388).)



506213.1
                                       -3-






10.1(a)*       Seventh  Amendment  to Lease  dated  February  13,  1986,  by and
               between New Market Partners III, Laing Properties,  Inc., General
               Partner,  as Landlord,  and the Company as tenant,  dated May 15,
               1996.

10.2*          Lease by and between Newmarket Partners I, Laing Properties, Inc.
               and Laing Management Company,  General Partner, as Landlord,  and
               the  Company as Tenant,  dated July 23,  1993.  (Incorporated  by
               reference to Exhibit 10.2 to the  Registrant's  Annual  Report on
               Form 10-K for the fiscal year ended December 31, 1993.)

10.3*          1993  Employee  Stock  Incentive  Plan  adopted  on July 6, 1993.
               (Incorporated  by reference  to Exhibit 10.3 to the  Registrant's
               Annual Report on Form 10-K for the fiscal year ended December 31,
               1993.)

10.4*          1989  Incentive  Stock  Option Plan for the  Company,  adopted on
               March 23, 1989. (Incorporated by reference to Exhibit 10.2 to the
               Registrant's Registration Statement on Form S-1 (No. 33-56388).)

10.5*          Incentive  Stock  Option  Plan,   dated  as  of  April  5,  1984.
               (Incorporated  by reference  to Exhibit 10.3 to the  Registrant's
               Registration Statement on Form S-1 (No. 33-56388).)

10.6*          Form of Stock  Option  Agreement  and Grant  under the  Incentive
               Stock Option and Employee Stock Incentive Plans. (Incorporated by
               reference  to  Exhibit  10.4  to  the  Registrant's  Registration
               Statement on Form S-1 (No. 33-56388).)

10.7*          CryoLife, Inc. Profit Sharing 401(k) Plan, as adopted on December
               17,  1991.  (Incorporated  by  reference  to Exhibit  10.5 to the
               Registrant's Registration Statement on Form S-1 (No. 33-56388).)

10.8*          Form of Supplemental  Retirement Plan, by and between the Company
               and its  Officers -- Parties to  Supplemental  Retirement  Plans:
               Steven G. Anderson,  Robert T. McNally, Gerald B. Seery, James C.
               Vander  Wyk,  Albert  E.  Heacox,  Kirby S.  Black,  and Edwin B.
               Cordell,  Jr.  (Incorporated  by reference to Exhibit 10.6 to the
               Registrant's Registration Statement on Form S-1 (No. 33-56388).)

10.9(a)*       Employment  Agreement,  by and  between the Company and Steven G.
               Anderson.  (Incorporated  by reference to Exhibit  10.9(a) to the
               Registrant's Annual Report on Form 10-K for the fiscal year ended
               December 31, 1995.)

10.9(b)*       Employment  Agreement,  by and  between the Company and Robert T.
               McNally.  (Incorporated  by reference  to Exhibit  10.7(b) to the
               Registrant's Registration Statement on Form S-1 (No. 33-56388).)

10.9(c)*       Employment  Agreement,  by and  between the Company and Albert E.
               Heacox.  (Incorporated  by  reference  to Exhibit  10.7(c) to the
               Registrant's Registration Statement on Form S-1 (No. 33-56388).)




506213.1
                                       -4-





10.9(d)*       Employment  Agreement,  by and  between  the Company and Edwin B.
               Cordell, Jr. (Incorporated by reference to Exhibit 10.9(f) to the
               Registrant's Annual Report on Form 10-K for the fiscal year ended
               December 31, 1994.)

10.9(e)*       Employment  Agreement,  by and  between the Company and Gerald B.
               Seery.  (Incorporated  by  reference  to  Exhibit  10.9(e) to the
               Registrant's Annual Report on Form 10-K for the fiscal year ended
               December 31, 1995.)

10.9(f)*       Employment  Agreement,  by and  between  the Company and James C.
               Vander Wyk, Ph.D.  (Incorporated  by reference to Exhibit 10.9(f)
               to the  Registrant's  Annual  Report on Form 10-K for the  fiscal
               year ended December 31, 1995.)

10.9(g)**      Employment  Agreement,  by and  between  the Company and Kirby S.
               Black, Ph.D.

10.10*         Form of Secrecy  and  Noncompete  Agreement,  by and  between the
               Company and its Officers.  (Incorporated  by reference to Exhibit
               10.9 to the Registrant's  Registration Statement on Form S-1 (No.
               33-56388).)

10.11*         Registration  Rights Agreement,  by and among the Company,  Galen
               Partners,  L.P., and Galen  Partners  International,  L.P.,  both
               Delaware   limited   partnerships,   dated   August   22,   1991.
               (Incorporated  by reference to Exhibit 10.13 to the  Registrant's
               Registration Statement on Form S-1 (No. 33-56388).)

10.12*         Technology Acquisition Agreement between the Company and Nicholas
               Kowanko, Ph.D., dated March 14, 1996.  (Incorporated by reference
               to Exhibit 10.14 to the  Registrant's  Annual Report on Form 10-K
               for the fiscal year ended December 31, 1995.)

10.13*         Option Agreement, by and between the Company and Duke University,
               dated  July  9,  1990,  as  amended  by  that  Option   Agreement
               Extension,  by and  between  the  parties,  dated  July 9,  1991.
               (Incorporated  by reference to Exhibit 10.20 to the  Registrant's
               Registration Statement on Form S-1 (No. 33-56388).)

10.14*         Research and License Agreement by and between Medical  University
               of South  Carolina and  CryoLife  dated  November  15,  1985,  as
               amended by Amendment to the Research and License  Agreement dated
               February  25,  1986 by and between the parties and an Addendum to
               Research and License Agreement by and between the parties,  dated
               March 4, 1986. (Incorporated by reference to Exhibit 10.23 to the
               Registrant's Registration Statement on Form S-1 (No. 33-56388).)

10.15*         Technical  Services  Agreement  by and  between  the  Company and
               Validation   Systems,   Inc.,   dated  as  of  January  1,  1994.
               (Incorporated  by  reference  to Exhibit 3.2 to the  Registrant's
               Annual Report on Form 10-K for the fiscal year ended December 31,
               1993.)

10.16*         CryoLife,  Inc. Non-Employee  Directors Stock Option Plan adopted
               on March 27, 1995. (Incorporated by reference to Exhibit 10.26 to
               the  Registrant's  Annual Report on Form 10-K for the fiscal year
               ended December 31, 1994.)



506213.1
                                       -5-






10.17*         Settlement    Agreement    between    the   Company   and   Bravo
               Cardiovascular,  Inc., dated February 14, 1995.  (Incorporated by
               reference to Exhibit 10.27 to the  Registrant's  Annual Report on
               Form 10-K for the fiscal year ended December 31, 1994.)

10.18*         Sale Agreement between the Company and Bravo Cardiovascular, Inc.
               dated  February 14, 1995.  (Incorporated  by reference to Exhibit
               10.28 to the  Registrant's  Annual  Report  on Form  10-K for the
               fiscal year ended December 31, 1994.)

10.19*         Private   Label   Agreement   between   the   Company  and  Bravo
               Cardiovascular,  Inc. dated February 14, 1995.  (Incorporated  by
               reference to Exhibit 10.29 to the  Registrant's  Annual Report on
               Form 10-K for the fiscal year ended December 31, 1994.)

10.20*         Consignment    Agreement    between   the   Company   and   Bravo
               Cardiovascular,  Inc. dated February 14, 1995.  (Incorporated  by
               reference to Exhibit 10.30 to the  Registrant's  Annual Report on
               Form 10-K for the fiscal year ended December 31, 1994.)

10.21*         Sale and Assignment  Agreement between the Company and Osteotech,
               Inc. dated July 17, 1995.  (Incorporated  by reference to Exhibit
               10.24 to the  Registrant's  Annual  Report  on Form  10-K for the
               fiscal year ended December 31, 1995.)

10.22*         Lease Agreement between the Company and Amli Land Development - I
               Limited  Partnership,  dated  April 18,  1995.  (Incorporated  by
               reference to Exhibit 10.26 to the  Registrant's  Annual Report on
               Form 10-K for the fiscal year ended December 31, 1995.)

10.23*         Preoccupancy and Construction  Agreement  between the Company and
               Amli Land  Development  - I Limited  Partnership  dated April 18,
               1995.   (Incorporated  by  reference  to  Exhibit  10.27  to  the
               Registrant's Annual Report on Form 10-K for the fiscal year ended
               December 31, 1995.)

10.24*         Funding Agreement between the Company and Amli Land Development -
               I Limited  Partnership  dated April 18,  1995.  (Incorporated  by
               reference to Exhibit 10.28 to the  Registrant's  Annual Report on
               Form 10-K for the fiscal year ended December 31, 1995.)

10.25*         Employee Stock Purchase Plan dated May 22, 1995. (Incorporated by
               reference to Exhibit 10.29 to the  Registrant's  Annual Report on
               Form 10-K for the fiscal year ended December 31, 1995.)

10.26*         Noncompetition   Agreement   between   the   Company  and  United
               Cryopreservation   Foundation,   Inc.  dated  September  11,1996.
               (Incorporated  by reference  to Exhibit 10.1 to the  Registrant's
               Quarterly Report on Form 10-Q for the quarter ended September 30,
               1996.)

10.27*         Noncompetition  Agreement  between the Company and QV, Inc. dated
               September 11, 1996. (Incorporated by reference to Exhibit 10.3 to
               the  Registrant's  Quarterly  Report on Form 10-Q for the quarter
               ended September 30, 1996.)




506213.1
                                       -6-





10.28*         Revolving\Term  Loan Facility between the Company and NationsBank
               N.A.,  dated  August 30,  1996.  (Incorporated  by  reference  to
               Exhibit 10.4 to the  Registrant's  Quarterly  Report on Form 10-Q
               for the quarter ended September 30, 1996.)

10.29*         Research   and  Option   Agreement   between   the   Company  and
               Biocompatibles  Limited  dated July 29,  1996.  (Incorporated  by
               reference to Exhibit 10.1 to the Registrant's Quarterly Report on
               Form 10-Q for the quarter ended June 30, 1996.)

10.30*         Technology  License  Agreement  between the Company and  Colorado
               State  University  Research  Foundation  dated  March  28,  1996.
               (Incorporated  by reference  to Exhibit 10.1 to the  Registrant's
               Quarterly  Report on Form 10-Q for the  quarter  ended  March 31,
               1996.)

10.31*         Noncompetition   Agreement   between   the   Company  and  United
               Transplant   Foundation,   Inc.   dated   September   11,   1996.
               (Incorporated  by reference  to Exhibit 10.2 to the  Registrant's
               Quarterly Report on Form 10-Q for the quarter ended September 30,
               1996.)

11.1*          Statement re: Computation of Per Share Earnings.

13.*           1996 Annual  Report to  Stockholders.  The portions of the Annual
               Report  which  are  not  specifically   incorporated   herein  by
               reference are provided for informational purposes only.

21.1*          Subsidiaries of CryoLife, Inc.

23.1*          Consent of Independent Auditors.

23.2*          Consent of Independent Auditors.

27.1*          Financial Data Schedule 
               ----------------------

               *        Previously filed.
               **       Filed herewith.


                        3.    B.   Executive Compensation Plans and Arrangements

1.             1993  Employee  Stock  Incentive  Plan  adopted  on July 6, 1993.
               (Exhibit 10.2 to the Registrant's  Annual Report on Form 10-K for
               the fiscal year ended December 31, 1994.)

2.             1989  Incentive  Stock  Option Plan for the  Company,  adopted on
               March 23, 1989  (Exhibit  10.2 to the  Registrant's  Registration
               Statement on Form S-1 (No. 33-56388).)




506213.1
                                       -7-





3.             Incentive  Stock Option Plan,  dated as of April 5, 1984 (Exhibit
               10.3 to the Registrant's  Registration Statement on Form S-1 (No.
               33-56388).)

4.             Form of Stock  Option  Agreement  and Grant  under the  Incentive
               Stock Option and Employee Stock  Incentive Plans (Exhibit 10.4 to
               the  Registrant's   Registration   Statement  on  Form  S-1  (No.
               33-56388).)

5.             CryoLife, Inc. Profit Sharing 401(k) Plan, as adopted on December
               17, 1991 (Exhibit 10.5 to the Registrant's Registration Statement
               on Form S-1 (No. 33-56388).)

6.             Form of Supplemental  Retirement Plan, by and between the Company
               and its  Officers -- Parties to  Supplemental  Retirement  Plans:
               Steven G. Anderson,  Robert T. McNally, Gerald B. Seery, James C.
               Vander  Wyk,  Albert  E.  Heacox,  Kirby S.  Black  and  Edwin B.
               Cordell,  Jr.  (Exhibit  10.6  to the  Registrant's  Registration
               Statement on Form S-1 (No. 33-56388).)

7.             Employment  Agreement,  by and  between the Company and Steven G.
               Anderson.  (Exhibit  10.7(a)  to  the  Registrant's  Registration
               Statement on Form S-1 (No. 33-56388).)

8.             Employment  Agreement,  by and  between the Company and Robert T.
               McNally.   (Exhibit  10.7(b)  to  the  Registrant's  Registration
               Statement on Form S-1 (No. 33-56388).)

9.             Employment  Agreement,  by and  between the Company and Albert E.
               Heacox.   (Exhibit  10.7(c)  to  the  Registrant's   Registration
               Statement on Form S-1 (No. 33-56388).)

10.            Employment  Agreement,  by and  between the Company and Gerald B.
               Seery.  (Incorporated  by  reference  to  Exhibit  10.9(e) to the
               Registrant's  Annual  Report  on Form  10-K  for the  year  ended
               December 31, 1995.)

11.            Employment  Agreement,  by and  between  the Company and James C.
               Vander Wyk, Ph.D.  (Incorporated  by reference to Exhibit 10.9(f)
               to the Registrant's Annual Report on Form 10-K for the year ended
               December 31, 1995.)

12.            Employment  Agreement,  by and  between  the Company and Edwin B.
               Cordell, Jr. (Incorporated by reference to Exhibit 10.9(f) to the
               Registrant's Annual Report on Form 10-K for the fiscal year ended
               December 31, 1994.)

13.            CryoLife,  Inc. Non-Employee  Directors Stock Option Plan adopted
               on March 27, 1995. (Incorporated by reference to Exhibit 10.26 to
               the  Registrant's  Annual Report on Form 10-K for the fiscal year
               ended December 31, 1994.)

14.            Employee  Stock  Purchase  Plan.  (Incorporated  by  reference to
               Exhibit 10.29 to the Registrant's  Annual Report on Form 10-K for
               the fiscal year ended December 31, 1995.)

15.            Employment  Agreement  by and  between  the  Company and Kirby S.
               Black (Exhibit 10.9(g) to this Form 10-K.)



506213.1
                                       -8-




                  (b)      Reports on Form 8-K

The  Registrant  did not file a report on Form 8-K during the fourth  quarter of
the recently completed fiscal year.




                                   SIGNATURES

         Pursuant to the  requirements  of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                      CRYOLIFE, INC.


February 13, 1998                     By: /s/ Edwin B. Cordell, Jr.
                                      ------------------------------------------
                                      Edwin B. Cordell, Jr.
                                      Vice President and Chief Financial Officer




                                      -9-

506213.1


                                 EXHIBIT 10.9(g)

                              EMPLOYMENT AGREEMENT


         In consideration of the promises hereinafter contained, CryoLife, Inc.,
a Florida  corporation  ("we", "our" and "us") and Kirby S. Black ("you") hereby
agree as of the 26th day of June, 1995 to the following:

         1. Employment. We hereby employ you and you hereby accept employment on
the terms and conditions set forth below.  Your duties and  compensation are set
forth on the Exhibit attached hereto.

         2. Extent of Services. During your employment, you agree to devote your
full and  exclusive  time and  attention  to your  employment  duties and not to
engage in any other  business  activity  which  conflicts  or competes  with our
business or which reduces your  effectiveness  in  performing  your duties under
this Agreement unless you have first obtained our prior written consent.

         3. Benefits and Absences.  You are entitled to all benefits  offered by
us for which  you meet the  eligibility  requirements.  You are  subject  to the
obligations  concerning  absences  due to  disability,  sick  leave,  and  other
absences,  described in the current  benefit  summary  schedule,  and as revised
hereafter.

         4. Term and Termination.  Your employment shall commence on the date of
this Agreement. Both you and we shall have the right upon giving 30 days written
notice to the other to terminate with or without cause the employment under this
Agreement.  However,  if one party to this Agreement  terminates the employment,
the other  party may at his  option  effect  the  separation  immediately.  This
Agreement  shall  automatically  terminate  in the  event  of your  death.  Such
automatic  termination  shall  discharge  both  parties  hereto from any and all
further liability or responsibility to the other under this Agreement.

         5. Right to Change  Duties.  We reserve  the right to change the nature
and scope of your  duties.  In the event of any  transfer  to another  corporate
facility,  we shall  defray the  reasonable  cost of  transporting  you and your
family with household furnishing to your new location.

         6. Secrecy and Noncompetition. Your employment and continued employment
with us is  conditioned  upon your signing our standard  Secrecy and  Noncompete
Agreement  whose terms and  agreements  you agree to be bound by. You agree that
under no condition will any breach or infraction of this Agreement be assertable
as a defense to any action or  responsibility  incurred by you under the Secrecy
and Noncompete Agreement.

         7. Your  Warranties.  You present and warrant that you will not utilize
or disclose any trade  secrets or  proprietary  information  of others to us and
that the only secrecy and/or noncompetition  agreements you have with others are
identified on the attached exhibit.

         8.  Miscellaneous.  This  Agreement  may not be changed  or  terminated
orally and no change,  termination or attempted waiver of the provisions  hereof
shall be binding  unless in writing and signed by the parties  against  whom the
same is sought to be enforced;  provided, however, that the compensation paid to
you  hereunder  may be increased at any time by us without in any way  affecting
any other term or condition of this Agreement  which in all other respects shall
remain in force and effect. This Agreement



506213.1





shall be governed by the laws of the State of Georgia.

         IN WITNESS  WHEREOF,  this  Agreement has been duly executed on the day
and year first above written.



                                         CRYOLIFE, INC.



                                         By: ___________________________________
                                         Its: __________________________________



                                         EMPLOYEE


                                         ---------------------------------------









506213.1




                         Exhibit to Employment Agreement



Duties:                    Vice President, Research & Development




Compensation:              $8,333.33/Month Plus Company
                           Fringe Benefits

Secrecy and
Noncompetition
Agreements
With Others*:              University of California





            (*Copies of these must be promptly provided to CryoLife)




506213.1